Early T1D Screening Guide; FDA Clears Mint Patch Pump; GLP-1s and Fertility
[post_content]
Disclaimer: This article has been automatically aggregated from
An international consensus panel outlined the first clinical framework for implementing general-population screening for islet autoantibodies to catch early-stage type 1 diabetes. (Diabetologia)
Another international consensus offered updated recommendations tailored specifically for smoking cessation in people with type 2 diabetes. (Diabetes Research and Clinical Practice)
Novo Nordisk, maker of the blockbuster drug semaglutide (Ozempic, Wegovy), will slim down its name to just Novo as part of a rebranding effort, though Novo Nordisk A/S will remain its legal name. (Reuters via AOL)
The FDA cleared Beta Bionics’ Mint, a smartphone-controlled patch pump that features a reusable and disposable design, requires no recharging, and integrates with major continuous glucose monitors.
In a small randomized trial, eating only between 12:00 p.m. and 8:00 p.m. led to a greater reduction in HbA1c levels among adults with type 1 diabetes compared with continuous daily calorie restriction. (Diabetes Care)
Tennis player Alexander Zverev, who has type 1 diabetes, could be seen checking his blood sugar levels on a phone multiple times during his U.S. Open final win on Sunday. (Athlon Sports)
High-frequency spinal cord stimulation provided greater pain relief and sensory improvement compared with conventional medical management for patients with painful diabetic neuropathy in a randomized trial. (Diabetes Care)
The prevalence of clinical obesity among U.S. adolescents increased from 14.2% in 1999-2000 to 18.2% in 2021-2023, though preclinical obesity rates remained stable, national survey data showed. (JAMA Pediatrics)
A new Endocrine Society scientific statement outlined future research priorities aimed at delivering more personalized, long-term care for people living with obesity. (Endocrine Reviews)
Smoking at any point in life and exposure to second-hand smoke may negatively affect fertility, a World Health Organization report warned.
Review authors highlighted an urgent need for clinical trials investigating GLP-1 drugs in reproductive-age individuals to evaluate fertility outcomes and pregnancy safety. (Endocrinology and Metabolism Clinics of North America)
An increasing number of women are seeking off-label testosterone therapy to manage menopause symptoms, but many are facing prescription delays and pharmacy refusals. (Reuters via AOL)
Sen. Kirsten Gillibrand (D-N.Y.) will convene the first-ever congressional hearing dedicated to federal research funding for menopause. (New York Times)
for informational purposes only. We do not claim ownership, accuracy, or liability for the content provided. All rights belong to the original publisher.